Home › NDC Lookup › Ingredients › Sodium Monofluorophosphate › 1480003401336
Hapee Outrageous Blue Chill 150 Sodium Monofluorophosphate .15 g/100g Gel, Dentifrice — NDC 1480003401336 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Hapee Outrageous Blue Chill 150 Sodium Monofluorophosphate .15 g/100g Gel, Dentifrice — NDC 1480003401336

by LAMOIYAN CORPORATION · 54 CARTON in 1 BOX (GS1:14800034013365) / 1 TUBE in 1 CARTON (GS1:4800034013368) / 192 g in 1 TUBE

This is a package of Hapee Outrageous Blue Chill 150 Sodium Monofluorophosphate .15 g/100g Gel, Dentifrice from LAMOIYAN CORPORATION, marketed since May 2022 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 1480003401336
This package
Contains192 g in 1 tube Pack sizes2 compare ↓
Main listing for product 82426-0157 · Also comes in: 192 g 82426-157-01
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 1480003401336 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Listing certified through
Dec 31, 2027
Barcode (UPC)
4800034011562, 4800034011661, 4800034011357, 4800034011364 +4 more
FDA record last changed
Oct 1, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

Product NDC 82426-0157
11-digit billing NDC 1480003401336
RxCUI 1038995
UNII RU45X2JN0Z, C810JCZ56Q, 8ZYQ1474W7
UPC 4800034011562, 4800034011661, 4800034011357, 4800034011364 +4 more
Application # M021
SPL Set ID 14c14694-6149-40a8-aff2-660d39f7e0c1
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-05-20
Route DENTAL
Dosage form GEL, DENTIFRICE
Substance SODIUM MONOFLUOROPHOSPHATE
Quick answers
  • RxCUI (RxNorm): 1038995
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
  • FDA openFDA NDC Directory · synced Oct 1, 2026
  • FDA label on DailyMed · label index refreshed Oct 5, 2026
  • RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
  • Medi-Span GPI (licensed)
  • First Databank (licensed) · refreshed Oct 1, 2026

RxNorm drug class

This medicine belongs to the Caries prophylactic agents class.

Drug family (ATC) Caries prophylactic agents, Fluoride
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is an over-the-counter toothpaste gel marketed under FDA's monograph rules for dental products. It contains sodium monofluorophosphate, a fluoride compound that is commonly used in toothpastes to help strengthen tooth enamel and reduce cavities. The product is applied to teeth by brushing and is intended for routine oral care.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 192 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
1480003401336 You're viewing this Main listing 54 CARTON in 1 BOX (GS1:14800034013365) / 1 TUBE in 1 CARTON (GS1:4800034013368) / 192 g in 1 TUBE 2022-05-27 — Active
82426-0157-01 82426-157-01 1 TUBE in 1 CARTON / 192 g in 1 TUBE 2022-05-27 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 54 carton in 1 box / 1 tube in 1 carton / 192 g in 1 tube.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Colgate Optic White Pro Series Enamel Renewal Soothing Mint 1.5 mg/g 35000-0791-62 Colgate-Palmolive 2 tubes — — FDA listed —
Colgate Optic White Pro Series High Impact White 1.5 mg/g 35000-0792-63 Colgate-Palmolive 1 tube — — FDA listed —
Colgate Optic White Advanced Enamel Strength 1.5 mg/g 35000-0921-32 Colgate-Palmolive 1 tube — — FDA listed —
Colgate Optic White Advanced Oxygenating White 1.5 mg/g 35000-0933-32 Colgate-Palmolive 1 tube — — FDA listed —
Colgate Optic White Advanced Vibrant Clean 1.5 mg/g 35000-0979-32 Colgate-Palmolive 1 tube — — Discontinued —
Colgate Optic White Pro Series Hi White 1.5 mg/g 65954-0841-63 Mission 1 tube — — FDA listed —
Colgate Optic White Pro Series 11.4 mg/g 65954-0845-62 Mission 2 tubes — — FDA listed —
Crest 3D White Advanced 1.7 mg/g 69423-0752-30 The 1 tube — — FDA listed —
Crest 3D White Brilliance Pro Ultra White 1.7 mg/g 69423-0760-30 The 1 tube — — FDA listed —
ARC 2 in 1 Whitening and Anticavity 1.7 mg/g 69423-0837-30 The 1 tube — — FDA listed —
Crest 3D White Brilliance Advanced Whitening Fresh Mint 1.7 mg/g 69423-0959-04 The 1 cello — — FDA listed —
Hapee Explosive Menthol Red 150 .15 g/100g 1480003401156 LAMOIYAN 1 tube — — FDA listed —
Hapee Fresh And Cool White 150 .15 g/100g 1480003401136 LAMOIYAN 1 tube — — FDA listed —
Hapee Fresh And Cool White 100 .15 g/100g 1480003401135 LAMOIYAN 1 tube — — FDA listed —
Hapee Gumtect Gum Care .15 g/100g 1480003401325 LAMOIYAN 1 tube — — FDA listed —
Hapee Fresh Green Outburst 100 .15 g/100g 1480003401165 LAMOIYAN 1 tube — — FDA listed —
Hapee Fresh Green Outburst 150 .15 g/100g 1480003401166 LAMOIYAN 1 tube — — FDA listed —
Hapee Outrageous Blue Chill 150 .15 g/100g 1480003401336 LAMOIYAN 1 tube — — FDA listed —
Crest 3D White Deep Stain Remover Dazzling Mint 2 mg/g 84126-0610-21 The 1 tube — — FDA listed —
Crest 3D White Deep Stain Remover Ultra White 2 mg/g 84126-0611-02 The 2 tubes — — FDA listed —
Crest 3D White Brilliance Pro Ultra White 1.7 mg/g 84126-0616-38 The 1 tube — — FDA listed —
Crest 3D White Deep Stain Remover Brilliant White 2 mg/g 84126-0626-03 The 2 tubes — — FDA listed —
Crest 3D White Deep Stain Remover Enamel Strength 2 mg/g 84126-0644-21 The 1 tube — — FDA listed —
Brush Buddies 2 VALUE PACK CAVITY PROTECTION ANTI-CAVITY FLUORIDE .15 g/100g 70108-0185-01 Ashtel 2 tubes — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
May 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white / red / green / blue
FlavorMenthol
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Inactive-ingredient data isn’t available for this listing.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.
  • FDA label on DailyMed · label index refreshed Oct 5, 2026
  • FDA openFDA NDC Directory · synced Oct 1, 2026

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerLAMOIYAN CORPORATION
FDA applicationM021 (OTC MONOGRAPH DRUG)
Labeler code82426
First marketedMay 2022
Product typeHuman Otc Drug
Portfolio8 products on file

More NDCs from LAMOIYAN CORPORATION labeler code 82426

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
  • FDA openFDA NDC Directory · synced Oct 1, 2026
  • Drugs@FDA

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 5 words ▾

Use Helps protect against cavities

⏱️ Dosage and Administration 22 words ▾

Direction Brush thoroughly, preferably after each meal or at least twice a day. Do not swallow. Rinse and spit out after use.

⚠️ Warnings 34 words ▾

WARNINGS AND PRECAUTIONS SECTION Children of six years and younger: Use a pea-sized amount for supervised brushing to minimize swallowing. In case of intake of fluoride from other sources, consult a dentist or doctor.

🧪 Active Ingredient 15 words ▾

Active Ingredient Sodium Monofluorophosphate: 1.14% w/w (1,500 ppm fluoride as added) (0.15% w/w fluoride ion)

🧪 Inactive Ingredients 21 words ▾

Inactive Ingredients Sorbitol, Water, Hydrated Silica, Sodium Lauryl Sulfate, Flavor, PEG-12, Cellulose Gum, Sodium Saccharin, Methylparaben, Mica, Propylparaben, FD&C Red No.40

🎯 Purpose 1 words ▾

Anti-cavity

📄 Keep Out of Reach of Children 7 words ▾

Warning Keep out of reach of children

📄 Package Label / Principal Display Panel 52 words ▾

HAPEE EXPLOSIVE MENTHOL RED 150 EXPLOSIVE_MENTHOL_RED_150_ML

HAPEE FRESH AND COOL WHITE 150 ML FRESH_AND_COOL_WHITE_150ML

HAPEE FRESH AND COOL WHITE 100ML FRESH_AND_COOL_WHITE_100_ML

HAPEE GUMTECT GUM CARE HAPEE GUMTECT GUM CARE

HAPEE GUMTECT SENSITIVE 150 GUMTECT_SENSITIVE

HAPEE FRESH GREEN OUTBURST 100ML FRESH_GREEN_OUTBURST_100ML

HAPEE FRESH GREEN OUTBURST 150 ML FRESH_GREEN_OUTBURST_150ML

HAPEE OUTRSGEOUS BLUE CHILL OUTRAGEOUS_BLUE_CHILL_150_ML

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for HAPEE OUTRAGEOUS BLUE CHILL 150 (this brand).

Top reported reactions

Pelvic Fracture2
Abdominal Discomfort1
Abdominal Pain Upper1
Bone Metabolism Disorder1
Burning Sensation1
Cardiac Disorder1
Chest Pain1

Age at onset

Adult1

Reporter sex

9 reports
Male · 78%
Female · 22%

Serious outcomes

Hospitalization3
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 2 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes. Both numbers identify this exact package. The 11-digit form is the same code written without dashes, in the fixed 5-4-2 format used on insurance claims. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by LAMOIYAN CORPORATION. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (82426-0157-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
LAMOIYAN CORPORATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 1480003401166 · LAMOIYAN 82431-0101-03 · Ginger →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.